Cite
HARVARD Citation
Serrano, P. et al. (2019). Clinical Development and Initial Approval of Novel Immune Checkpoint Inhibitors in Oncology: Insights From a Global Regulatory Perspective. Clinical pharmacology & therapeutics. 105 (3), pp. 582-597. [Online].